News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 541–576
- Matches
- 3030
- Sources here
- 19
- Companies here
- 27
Active search
3030 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
WaterBridge (WBI) Raised Guidance Again, So Why Did Shares Slip?
WaterBridge Infrastructure (NYSE:WBI) just posted record quarterly revenue, raised its full-year outlook for the second straight quarter, and closed a wave of acquisitions that doubled its waste management footprint in the Delaware Basin. Yet the stock fell 1.73% around the release. For a produced …
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
BridgeBio Pharma, Inc. announced the pricing of an oversubscribed secondary offering of 5,000,000 shares of its common stock by KKR Genetic Disorder L.P. The company itself is not selling shares and will not receive any proceeds from the offering. This transaction aims to further …
KKR to Sell 5M BridgeBio Shares; Company Receives No Proceeds
BridgeBio Pharma announced the pricing of a secondary offering of 5,000,000 shares of its common stock by existing shareholder KKR Genetic Disorder L.P. BridgeBio will not issue any shares or receive any proceeds from this transaction, which is expected to close on August 17, …
BridgeBio Pharma (BBIO) holders to resell 5M shares in $390M offering
BridgeBio Pharma is facilitating a secondary offering where a KKR-affiliated selling stockholder will sell 5,000,000 shares of common stock at $78.00 per share, totaling $390 million. BridgeBio Pharma will not receive any proceeds from this transaction, as all net proceeds will go to the …
Kolibri Global Energy Inc. Stock Surges 5.67% as Trading Activity Spikes and Market Attention Builds
Kolibri Global Energy Inc. (TSX:KEI) experienced a 5.67% stock surge on August 13, 2026, driven by a spike in trading activity, though the exact catalyst remains unverified. The company is an oil and natural gas producer focused on its Tishomingo field in Oklahoma. Investors …
QV Investors Inc. Sells 34,230 Shares of Enbridge Inc $ENB
QV Investors Inc. reduced its stake in Enbridge Inc. (NYSE:ENB) by 4.7% during the second quarter, selling 34,230 shares but still holding 696,095 shares valued at $37.7 million. Enbridge reported quarterly earnings of $0.46 per share, surpassing estimates, and declared a quarterly dividend of …
Bristol Myers Squibb announces new $2.3bn campus in the US
Bristol Myers Squibb has announced a new $2.3 billion multi-modal manufacturing campus in Houston, Texas, creating nearly 500 skilled jobs. This investment is part of BMS's $40 billion commitment to the US, aiming to accelerate the delivery of next-generation medicines. The campus's modular design …
Exchange Traded Concepts LLC Sells 89,348 Shares of Enbridge Inc $ENB
Exchange Traded Concepts LLC reduced its stake in Enbridge Inc. by 7.2% in the second quarter, selling 89,348 shares and retaining 1.14 million shares valued at approximately $62 million. Enbridge reported strong quarterly results, beating analyst expectations for both EPS and revenue, and declared …
Does Cellebrite DI’s Lowered 2026 Outlook and New CEO Reset Its AI Narrative (CLBT)?
In August 2026, Cellebrite DI Ltd. reported second-quarter results showing revenue of US$131.14 million and net income of US$6.37 million, while lowering its full-year 2026 revenue guidance to US$555 million–US$561 million and announcing Shiven Ramji's appointment as CEO, succeeding Thomas E. Hogan. The combination …
Earnings call transcript: Kolibri Global Energy posts record Q2 2026 revenue
Kolibri Global Energy reported record Q2 2026 revenue of $22.5 million, exceeding Wall Street estimates, driven by a 109% year-over-year increase due to higher production and realized prices. Despite a slight miss on EPS, the stock rose as investors focused on the company's strong …
ETFs Investing in Cellebrite DI Ltd. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Cellebrite DI Ltd. (CLBT), providing detailed information such as market value, weight, issuer, management style, expense ratio, AUM, price change, relative volume, and 3-year NAV total return for each fund. It aims …
Cellebrite DI (CLBT) Names Shiven Ramji As Next CEO
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cellebrite DI (NasdaqGS: CLBT) announced a planned CEO transition, with Shiven Ramji set to succeed Thomas E. Hogan. Ramji joined Cellebrite DI earlier this year as President, …
Fabrinet's COO Sells Nearly 7,000 Shares for $3.6 Million. Here's What That Means for Investors.
Key Points The transaction involved 6,933 shares with an estimated value of ~$3.6 million based on the August 11, 2026 valuation price. The disposition represents a 26% reduction in the insider's direct equity holdings. Following the transaction, the executive maintains a direct position of …
Cellebrite (CLBT) CEO gets 339,484-share award and withholds 139,713 shares for taxes
Cellebrite DI Ltd. CEO Thomas E. Hogan received an award of 339,484 ordinary shares on August 11, 2026, after performance conditions from awards granted in September 2025 were met. Subsequently, 139,713 shares were withheld and sold on August 12, 2026, at a weighted average …
Glazer Capital (DBRG) discloses 2.70% beneficial stake in DigitalBridge Group
Glazer Capital, LLC and its managing member, Paul J. Glazer, have reported a 2.70% beneficial ownership stake in DigitalBridge Group, Inc. (DBRG), amounting to 4,927,041 shares of Class A common stock. The shares are held by funds and managed accounts where Glazer Capital acts …
Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)
Levi & Korsinsky, LLP has announced an investigation into Cellebrite DI Ltd. (CLBT) following a significant stock drop of over 30% after the company's Q2 2026 results. The investigation focuses on whether Cellebrite made misleading statements regarding its 2026 annual recurring revenue (ARR) and …
Tranche Update on British American Tobacco p.l.c.'s Equity Buyback Plan announced on March 18, 2024.
British American Tobacco p.l.c. provided an update on its equity buyback plan, originally announced on March 18, 2024. Between July 1, 2025, and December 31, 2025, the company repurchased over 16 million shares for approximately £649.85 million. This latest tranche brings the total repurchased …
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
Key Points Earlier this month, AstraZeneca and Bristol Myers Squibb became the subject of merger rumors. Investors reacted negatively to the rumors, even if on paper such a deal would create an oncology-focused big pharma powerhouse worth around $400 billion. Considering regulatory uncertainty and …
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1%Fabrinet (FN) COO Harpal Gill gains 12,849 shares from PSU vesting
Fabrinet's President & COO, Harpal Gill, acquired 12,849 Ordinary Shares through the vesting of performance-based restricted share units (PSUs) on August 11, 2026. These PSUs, granted on August 22, 2024, vested because pre-established performance targets were exceeded and certified by the Compensation Committee. Concurrently, …